Peptide APIs
-
NMN
Preclinical thiab thaum ntxov tib neeg cov kev tshawb fawb qhia NMN yuav txhawb nqa lub neej ntev, lub cev muaj zog, thiab kev txawj ntse.
API nta:
Siab purity ≥99%
Pharmaceutical-qib, haum rau qhov ncauj los yog txhaj tshuaj formulations
Ua raws li GMP-zoo li tus qauv
NMN API yog qhov zoo tshaj plaws rau kev siv tshuaj tiv thaiv kev laus, kev kho mob metabolic, thiab kev tshawb fawb ntev.
-
Glucagon
Glucagon yog ib qho tshuaj peptide ntuj siv los ua kev kho mob xwm txheej ceev rau kev mob ntshav qab zib mellitus hnyav thiab kawm txog nws lub luag haujlwm hauv kev tswj cov metabolism, kev poob phaus, thiab kev kuaj mob plab.
-
Motixafortide
Motixafortide yog ib qho hluavtaws CXCR4 antagonist peptide tsim los txhawb cov kab mob hematopoietic qia hlwb (HSCs) rau kev hloov pauv hauv autologous thiab tseem tau kawm hauv oncology thiab immunotherapy.
-
Glepaglutide
Glepaglutide yog ib qho kev ua haujlwm ntev GLP-2 analog uas tsim los rau kev kho mob plab plob tsis so tswj (SBS). Nws txhim kho txoj hnyuv nqus thiab kev loj hlob, pab cov neeg mob txo qis kev vam khom ntawm cov khoom noj khoom haus parenteral.
-
Elamipretide
Elamipretide yog mitochondria-targeted tetrapeptide tsim los kho cov kab mob tshwm sim los ntawm mitochondrial dysfunction, nrog rau thawj mitochondrial myopathy, Barth syndrome, thiab lub plawv tsis ua hauj lwm.
-
Pegcetacoplan
Pegcetacoplan yog ib qho pegylated cyclic peptide uas ua raws li lub hom phiaj C3 ntxiv inhibitor, tsim rau kev kho mob ntawm cov kab mob sib ntxiv xws li paroxysmal nocturnal hemoglobinuria (PNH) thiab thaj chaw atrophy (GA) hauv cov hnub nyoog ntsig txog macular degeneration.
-
Palopegteriparatide
Palopegteriparatide yog ib tug ntev-acting parathyroid hormone receptor agonist (PTH1R agonist), tsim los rau kev kho mob ntawm mob hypoparathyroidism. Nws yog ib qho pegylated analogue ntawm PTH (1-34) tsim los muab cov kev cai calcium uas ruaj khov nrog kev noj ib zaug ib lim tiam.
-
GHRP-6
GHRP-6 (Growth Hormone Releasing Peptide-6) yog ib qho hluavtaws hexapeptide uas ua raws li kev loj hlob hormone secretagogue, stimulating lub cev lub ntuj tso tawm ntawm kev loj hlob hormone (GH) los ntawm activating GHSR-1a receptor.
API nta:
Purity ≥99%
Tsim los ntawm solid-phase peptide synthesis (SPPS)
Muab rau R & D thiab kev lag luam siv
GHRP-6 yog ntau yam kev tshawb fawb peptide rau kev txhawb nqa metabolic, kev tsim cov leeg nqaij, thiab kev hloov kho hormonal.
-
GHRP-2
GHRP-2 (Growth Hormone Releasing Peptide-2) yog ib qho hluavtaws hexapeptide thiab muaj zog loj hlob hormone secretagogue, tsim los txhawb lub ntuj tso tawm ntawm kev loj hlob hormone (GH) los ntawm kev ua kom GHSR-1a receptor nyob rau hauv hypothalamus thiab pituitary.
API nta:
Purity ≥99%
Muaj rau R & D thiab cov khoom lag luam, nrog rau cov ntaub ntawv QC tag nrho
GHRP-2 yog ib qho tseem ceeb tshawb fawb peptide hauv kev ua haujlwm ntawm endocrinology, tshuaj kho dua tshiab, thiab kev kho hnub nyoog.
-
Hexarelin
Hexarelin yog ib qho hluavtaws loj hlob hormone secretagogue peptide (GHS) thiab muaj zog GHSR-1a agonist, tsim los txhawb kev loj hlob hormone (GH) tso tawm. Nws belongs rau ghrelin mimetic tsev neeg thiab yog tsim los ntawm 6 amino acids (ib hexapeptide), muab kev txhim kho metabolic stability thiab muaj zog GH-tso tawm los piv rau cov analogs ua ntej xws li GHRP-6.
API nta:
Purity ≥ 99%
Ua los ntawm solid-phase peptide synthesis (SPPS)
GMP-zoo li cov qauv, tsis tshua muaj endotoxin thiab hnyav residues
Flexible mov: R & D rau kev lag luam nplai
-
Melanotan II
API nta:
purity siab ≥ 99%
Synthesized ntawm solid-phase peptide synthesis (SPPS)
Tsawg endotoxin, tsawg residual kuab tshuaj
Muaj nyob rau hauv R & D rau kev lag luam nplai -
Melanotan 1
Melanotan 1 API yog tsim los siv cov txheej txheem peptide synthesis (SPPS) thev naus laus zis raws li kev tswj hwm zoo li GMP.
-
Siab purity ≥99%
-
Solid-phase peptide synthesis (SPPS)
-
GMP zoo li cov qauv tsim khoom
-
Cov ntaub ntawv tag nrho: COA, MSDS, cov ntaub ntawv ruaj khov
-
Scalable mov: R & D mus rau qib lag luam
-